HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Successful unrelated cord blood transplantation for homozygous α-thalassemia.

Abstract
A now 10-year-old Laotian female was delivered at 30-week gestation by cesarean section because of severe hydrops. Fetal blood sampling revealed homozygous α-thalassemia. After immediate resuscitation, the infant was supported with frequent red cell transfusions. At 44 months of age, she received a 5 of 6 human leukocyte antigen-matched unrelated cord blood transplantation. She was treated with phlebotomy and chelation therapy with Deferasirox for correction of hemosiderosis and has been transfusion-independent since 41 days after transplant. She is currently 6 years after transplantation with stable, 100% donor engraftment, resolved iron overload, and normal growth and development.
AuthorsBurak Gumuscu, Elizabeth I Thompson, Alfred C Grovas, Terrence L Zach, Phyllis I Warkentin, Peter F Coccia
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 35 Issue 7 Pg. 570-2 (Oct 2013) ISSN: 1536-3678 [Electronic] United States
PMID23337553 (Publication Type: Case Reports, Journal Article)
Topics
  • Blood Transfusion
  • Chelation Therapy
  • Child
  • Cord Blood Stem Cell Transplantation
  • Female
  • Homozygote
  • Humans
  • Iron Overload (etiology, therapy)
  • Phlebotomy
  • Treatment Outcome
  • alpha-Thalassemia (complications, genetics, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: